Salvador Bruno

616 total citations
23 papers, 472 citations indexed

About

Salvador Bruno is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Salvador Bruno has authored 23 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Salvador Bruno's work include Nausea and vomiting management (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Salvador Bruno is often cited by papers focused on Nausea and vomiting management (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Salvador Bruno collaborates with scholars based in United States, France and Italy. Salvador Bruno's co-authors include Raymond B. Weiss, John S. Penta, John S. Macdonald, Scott Antonia, Elihu J. Ledesma, Sophie Dessureault, R B Weiss, Steven E. Finkelstein, Lawrence Berk and Eduardo M. Sotomayor and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Urology and Urology.

In The Last Decade

Salvador Bruno

23 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salvador Bruno United States	11	229	102	70	63	63	23	472
Richard A. Lutes United States	7	94 0.4×	80 0.8×	25 0.4×	30 0.5×	68 1.1×	8	346
Maria Vadiaka Greece	13	423 1.8×	67 0.7×	30 0.4×	75 1.2×	140 2.2×	37	697
K. Beerblock France	10	404 1.8×	95 0.9×	17 0.2×	75 1.2×	53 0.8×	22	532
Owens Ah United States	11	156 0.7×	46 0.5×	25 0.4×	31 0.5×	110 1.7×	21	550
Isabel Blancas Spain	11	269 1.2×	130 1.3×	32 0.5×	31 0.5×	89 1.4×	45	508
Virginia Davenport United States	12	136 0.6×	159 1.6×	47 0.7×	150 2.4×	134 2.1×	21	639
W Scheef Germany	10	141 0.6×	153 1.5×	15 0.2×	61 1.0×	102 1.6×	23	410
Gerd Lorenz Germany	14	114 0.5×	70 0.7×	33 0.5×	133 2.1×	190 3.0×	36	586
Mariangela Bella Italy	7	180 0.8×	55 0.5×	17 0.2×	224 3.6×	116 1.8×	12	491

Countries citing papers authored by Salvador Bruno

Since Specialization

Citations

This map shows the geographic impact of Salvador Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvador Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvador Bruno more than expected).

Fields of papers citing papers by Salvador Bruno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvador Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvador Bruno. The network helps show where Salvador Bruno may publish in the future.

Co-authorship network of co-authors of Salvador Bruno

This figure shows the co-authorship network connecting the top 25 collaborators of Salvador Bruno. A scholar is included among the top collaborators of Salvador Bruno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvador Bruno. Salvador Bruno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Carballido, Estrella M., Arturo Anguiano, Bijal Shah, et al.. (2013). B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/<b><i>ZMYM2 (ZNF198)-FGFR1</i></b>: Rare Case and Review of the Literature. Acta Haematologica. 130(3). 127–134. 7 indexed citations

2.

Liu, Jane Jijun, Ling Zhang, Ernesto Ayala, et al.. (2011). Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review. Leukemia Research. 35(12). 1571–1577. 82 indexed citations

3.

Antonia, Scott, et al.. (2010). Systemic Therapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future. Cancer Control. 17(2). 120–129. 34 indexed citations

4.

Narbaitz, Marina, et al.. (2002). Cytogenetic, FISH, and molecular studies in a case of B‐cell chronic lymphocytic leukemia with karyotypic evolution. European Journal Of Haematology. 69(5-6). 309–314. 8 indexed citations

5.

Bruno, Salvador, E. Mickiewicz, Luis Alberto Gaitán-Cepeda, et al.. (1995). Phase II Trial of Weekly IV Vinorelbine as a Single Agent in First-Line Advanced Breast Cancer Chemotherapy. American Journal of Clinical Oncology. 18(5). 392–396. 72 indexed citations

6.

Neri, B, D Pantalone, F Andréoli, et al.. (1993). Epidoxorubicin and high dose leucovorin plus 5-fluorouracil in advanced gastric cancer. Anti-Cancer Drugs. 4(3). 323–326. 4 indexed citations

7.

Han, Tao, Takayuki Nemoto, Elihu J. Ledesma, & Salvador Bruno. (1983). Enhancement of T lumphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients. International Journal of Immunopharmacology. 5(1). 11–15. 13 indexed citations

8.

Pj, Creaven, et al.. (1982). Dialogue en enfer. PubMed. 66(1). 81–4. 4 indexed citations

9.

Bruno, Salvador, Gerald B. Grindey, Sigmund F. Zakrzewski, et al.. (1982). Phase I study of high-dose methotrexate with thymidine and low-dose leucovorin.. PubMed. 42(11). 4824–6. 3 indexed citations

10.

Penta, John S., et al.. (1982). PCNU. American Journal of Clinical Oncology. 5(1). 9–12. 3 indexed citations

11.

Weiss, R B & Salvador Bruno. (1982). Hypersensitivity Reactions to Cancer Chemotherapeutic Agents. The Journal of Urology. 127(4). 836–836. 3 indexed citations

12.

Bruno, Salvador, et al.. (1982). Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma. American Journal of Clinical Oncology. 5(1). 69–72. 2 indexed citations

13.

Bruno, Salvador, et al.. (1982). Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma. American Journal of Clinical Oncology. 5(1). 53–60. 1 indexed citations

14.

Bruno, Salvador, et al.. (1982). Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma. American Journal of Clinical Oncology. 5(1). 53–60. 16 indexed citations

15.

Penta, John S., et al.. (1981). Treatment of cancer chemotherapy-induced nausea and vomiting. 35 indexed citations

16.

Bruno, Salvador, et al.. (1981). Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland.. PubMed. 4(3). 301–7. 16 indexed citations

17.

Weiss, Raymond B. & Salvador Bruno. (1981). Hypersensitivity Reactions to Cancer Chemotherapeutic Agents. Annals of Internal Medicine. 94(1). 66–72. 87 indexed citations

18.

Bruno, Salvador, et al.. (1981). 2'-deoxycoformycin. A new anticancer agent.. PubMed. 4(2). 209–13. 6 indexed citations

19.

Han, Tao, Takayuki Nemoto, Elihu J. Ledesma, Salvador Bruno, & Willem K. Amery. (1981). Monocyte-mediated suppression of T lymphocyte proliferative response in breast and colorectal cancer patients: Specific action of levamisole on suppressor monocytes. International Journal of Immunopharmacology. 3(1). 103–111. 10 indexed citations

20.

Penta, John S., et al.. (1981). Clinical Trials with Antiemetic Agents in Cancer Patients Receiving Chemotherapy. The Journal of Clinical Pharmacology. 21(S1). 11S–22S. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact